Boothbay Fund Management’s Verona Pharma VRNA Stock Holding History

Boothbay Fund Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,300	Closed	-$322K	–	1963
2024 Q2	$322K	Buy	+22,300	New	+$326K	0.01%	1136

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Boothbay Fund Management's VRNA Position: Q4 2025 in Review

Boothbay Fund Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 20,150 shares — an estimated $2.15M sold.

Boothbay Fund Management first reported a position in VRNA in Q2 2022 and held it in 14 quarters. The position peaked at $45.7M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Boothbay Fund Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Boothbay Fund Management sold 20,150 Verona Pharma shares in Q4 2025, an estimated $2.15M.
Boothbay Fund Management first reported a position in Verona Pharma in Q2 2022 and held it in 14 quarters.
Boothbay Fund Management's Verona Pharma position peaked at $45.7M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.